Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar

Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar

BACKGROUND: Plasmodium falciparum resistance to artemisinins, the first line treatment for malaria worldwide, has been reported in western Cambodia. Resistance is characterized by significantly delayed clearance of parasites following artemisinin treatment. Artemisinin resistance has not previously...

Descripció completa

Dades bibliogràfiques
Autors principals:	Kyaw, M, Nyunt, M, Chit, K, Aye, M, Aye, K, Lindegardh, N, Tarning, J, Imwong, M, Jacob, C, Rasmussen, C, Perin, J, Ringwald, P
Format:	Journal article
Idioma:	English
Publicat:	Public Library of Science 2013

Ítems similars

Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
per: Myat P Kyaw, et al.
Publicat: (2013-01-01)

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
per: Das, J, et al.
Publicat: (2018)

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
per: Jesmin Permala Lohy Das, et al.
Publicat: (2018-03-01)

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam
per: Hien, T, et al.
Publicat: (2012)

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.
per: Hien, T, et al.
Publicat: (2012)

Characterization of Trichoderma species Isolated from Different Ecosystems in Myanmar
per: Khin Maung Nyunt, et al.
Publicat: (2020-03-01)

Genetic diversity of Plasmodium falciparum populations in southeast and western Myanmar
per: Than Naing Soe, et al.
Publicat: (2017-07-01)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
per: Smithuis, F, et al.
Publicat: (2006)

Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.
per: Htun, M, et al.
Publicat: (2017)

<it>In vivo</it> susceptibility of <it>Plasmodium falciparum</it> to artesunate in Binh Phuoc Province, Vietnam
per: Hien Tran, et al.
Publicat: (2012-10-01)

Clinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009–2013)
per: Myat Htut Nyunt, et al.
Publicat: (2017-08-01)

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
per: Win, AA, et al.
Publicat: (2016)

Seroprevalence of toxoplasmosis among reproductive-aged women in Myanmar and evaluation of luciferase immunoprecipitation system assay
per: Khin Myo Aye, et al.
Publicat: (2020-11-01)

The legend of laphet: A Myanmar fermented tea leaf
per: Thazin Han, et al.
Publicat: (2015-12-01)

Overview of pediatric oncology and hematology in Myanmar
per: Jay Halbert, et al.
Publicat: (2014-01-01)

Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
per: Das, D, et al.
Publicat: (2013)

Myanmar in Asean : Myanmar-Asean cooperation for development.
per: Hnin Hnin Aye.
Publicat: (2008)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
per: Jamsen, K, et al.
Publicat: (2011)

Comparison of microscopy and PCR for the detection of human Plasmodium species and Plasmodium knowlesi in southern Myanmar
per: Thu Zar Han, et al.
Publicat: (2017-08-01)

Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
per: Valea, I, et al.
Publicat: (2014)

No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China–Myanmar border
per: Fang Huang, et al.
Publicat: (2020-09-01)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
per: Awab, GR, et al.
Publicat: (2016)

Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
per: Smithuis, F, et al.
Publicat: (2004)

Comparison of microscopy and PCR for the detection of human Plasmodium species and Plasmodium knowlesi in southern Myanmar
per: Han, T.Z., et al.
Publicat: (2017)

Residual malaria among migrant workers in Myanmar: why still persistent and how to eliminate it?
per: Myat Htut Nyunt, et al.
Publicat: (2021-11-01)

Artemisinin resistance in Plasmodium falciparum malaria.
per: Dondorp, A, et al.
Publicat: (2009)

Spectrum of Upper Gastrointestinal Diseases in Patients Presenting with Dyspepsia—A First Report from Myanmar
per: Than Than Aye, et al.
Publicat: (2025-02-01)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
per: Lindegardh Niklas, et al.
Publicat: (2011-07-01)

Women's intergenerational intimate partner violence and household child abuse in Burma (Myanmar)
per: Stephanie Spaid Miedema, et al.
Publicat: (2022-03-01)

Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis
per: Aung Chan Minn, et al.
Publicat: (2018-01-01)

Myanmar Number Normalization for Text-to-Speech
per: Aye Mya Hlaing, et al.
Publicat: (2022-08-01)

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
per: Mcgready, R, et al.
Publicat: (2008)

The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated <it>Plasmodium falciparum </it>malaria
per: Singhasivanon Pratap, et al.
Publicat: (2009-09-01)

391 Health status of children with down syndrome in Myanmar
per: Kyaw Linn, et al.
Publicat: (2021-04-01)

Active surveillance for congenital rubella syndrome in Yangon, Myanmar
per: Thant Kyaw-Zin, et al.
Publicat: (2006-01-01)

Distribution of hepatitis B virus genotypes in the general population of Myanmar via nationwide study
per: Yi Yi Kyaw, et al.
Publicat: (2020-07-01)

Malaria incidence in Myanmar 2005–2014: steady but fragile progress towards elimination
per: Thet Thet Mu, et al.
Publicat: (2016-10-01)

The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.
per: Ambler, M, et al.
Publicat: (2009)

Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022
per: Phyu Win Ei, et al.
Publicat: (2025-03-01)

Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.
per: Guthmann, J, et al.
Publicat: (2008)